Surrozen, Inc. (SRZN)
22.14
-0.66
(-2.89%)
USD |
NASDAQ |
Feb 09, 16:00
22.15
+0.01
(+0.05%)
After-Hours: 07:16
Surrozen EPS Diluted (Quarterly) : -8.359 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -71.64M |
| Revenue (Quarterly) | 0.983M |
| Total Expenses (Quarterly) | 72.63M |
| Enterprise Value | 115.52M |
| Gross Profit Margin (Quarterly) | 93.90% |
| Profit Margin (Quarterly) | -7.29K% |
| Earnings Yield | -98.62% |
| Normalized Earnings Yield | -27.64 |